Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Psychiatr Prax ; 13(3): 104-11, 1986 May.
Artigo em Alemão | MEDLINE | ID: mdl-3737781

RESUMO

For several years now a working team of judges and physicians has been tackling the questions involved in the compulsory hospitalisation of mentally diseased patients. In the course of this teamwork the deficiencies and drawbacks of hospitalisation legislation have become glaringly evident. The problems of hospitalisation by law and under the legislation practised by Guardianship Courts, are compared by juxtaposition. It will be necessary to employ the principles of family law if the principle of care and need of treatment should receive priority over that of the potential danger to society (which dominates present hospitalisation legislation). However, before any adequate measures can be taken, it will be absolutely necessary to effect essential changes in the "law on care and protection of mentally ill patients" that has been in force in North Rhine Westphalia since the end of 1969. It will also be necessary to change the practices observed in enforcing this law.


Assuntos
Internação Compulsória de Doente Mental/legislação & jurisprudência , Prova Pericial/legislação & jurisprudência , Transtornos Mentais/terapia , Crime , Direito Penal , Comportamento Perigoso , Alemanha Ocidental , Humanos , Transtornos Mentais/diagnóstico , Transtornos Mentais/psicologia
2.
Artigo em Alemão | MEDLINE | ID: mdl-347465

RESUMO

Antidepressive therapy with maprotiline was accompanied by blood level determinations psychological clinical and electroencephalographical assessments. It was the aim of the study to introduce objective methods in psychotropic drug therapy and to look for a relationship between blood level and clinical outcome, EEG and psychological data. We found a "therapeutical window" of blood levels between 300 to 600 ng/ml of maprotiline (oral dose of 75 or 150 mg per day). There is also a relationship between clinical outcome rated by the Hamilton-Depression-Scale and the d2-cancellation-test.


Assuntos
Antracenos/uso terapêutico , Depressão/tratamento farmacológico , Maprotilina/uso terapêutico , Administração Oral , Adulto , Transtornos Psicóticos Afetivos/tratamento farmacológico , Idoso , Ensaios Clínicos como Assunto , Método Duplo-Cego , Avaliação de Medicamentos , Humanos , Maprotilina/administração & dosagem , Pessoa de Meia-Idade , Escalas de Graduação Psiquiátrica , Esquizofrenia/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...